NCT07769281 · Brooks Rehabilitation
Safety and Efficacy of NeuroTechR3 System for Upper Extremity Recovery After Stroke
(R3)
What this study is about
This research aims to understand the feasibility and effectiveness of using the NeuroTechR3 System to improve upper extremity function after stroke.
View original scientific description
This research aims to understand the feasibility and effectiveness of using the NeuroTechR3 System to improve upper extremity function after stroke.
Interventions
DEVICE
NeuroTechR3 Computer Rehabilitation System
Participants will complete three sessions a week, each lasting for 30 minutes. The sessions consist of upper extremity rehabilitation games on the computer.
Primary outcome measures
Upper Extremity Strength and Function
Time frame: Pre-intervention, mid-intervention within 3 days of discharging from the inpatient rehabilitation facility, and post-intervention at 6 weeks.
The Fugle-Meyer test is a simple, standardized test used to assess a person's exercise capacity and functional mobility. An increase in score reflects an improvement in mobility and upper extremity function.
Questionnaires
Time frame: Mid-intervention within 3 days of discharging from the inpatient rehabilitation facility and post-intervention at 6 weeks.
The System Usability Scale measures the perceived usability, ease of use, and learnability of the system. An increase in score indicates better usability.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- Age ≥18 years at the time of enrollment
- Diagnosed with stroke
- No other peripheral or central neurological condition limiting target upper extremity function (previous stroke is ok)
- Indicated for upper extremity training procedures by participant's treating physician, occupational therapist, or physical therapist
- Capable of providing informed consent
- Participant demonstrates active extension of wrist and activation of at least two other digits plus thumb activation
Exclusion criteria
- In the opinion of the investigators, the study is not safe or appropriate for the participant, and/or the participant is unlikely to return for the follow-up visits per the protocol to return the device at 4 weeks post discharge
- Visual impairment that would severely limit ability to see a computer screen for participation in sessions, including severe spatial neglect making the person unable to interact with an entire computer screen
- Inability to follow a 3-step motor command
- Severe upper extremity tone that will limit participation in study
- No internet access at home
- Severe receptive aphasia
- Severe arthritis that limits hand and arm movements
- Not independent in functional activities/mobility prior to stroke
Where
- Jacksonville, Florida
Collaborators
NeuroTechR3
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Aug 17, 2026 · Source of record for eligibility and locations